<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://vitalspanwire.com/news/eb613-osteoporosis-subgroup-bone-density-asbmr</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-13T21:01:35.485Z</news:publication_date><news:title>EB613 update reports larger bone-density gains in small osteoporosis subgroups</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/cancer-cachexia-weight-loss-episodes-prediction-study</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-13T16:01:43.663Z</news:publication_date><news:title>Cancer study maps weight-loss episodes and tests prediction across hospital cohorts</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/menopause-study-abrupt-laboratory-changes</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-13T11:01:30.763Z</news:publication_date><news:title>Menopause study maps abrupt laboratory changes, with interpretation disputed</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/melflufen-insula-glioblastoma-tumor-uptake</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-12T21:02:12.131Z</news:publication_date><news:title>Melflufen study reports drug uptake in three glioblastoma patients’ tumors</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/roxadustat-roxami-heart-attack-infarct-size-trial</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-12T16:02:09.806Z</news:publication_date><news:title>Roxadustat fails to reduce heart-attack damage in randomized trial</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/gimap6-artery-disease-mice-cardiovascular-risk</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-12T11:02:29.230Z</news:publication_date><news:title>GIMAP6 study identifies a genetic route to severe artery disease in mice</news:title></news:news></url></urlset>